KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
Market capitalization of KemPharm (KMPH)
Market cap: $0.20 Billion
As of April 2024 KemPharm has a market cap of $0.20 Billion. This makes KemPharm the world's 6922th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of KemPharm from 2015 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.20 B | 0% |
| 2023 | $0.20 B | 26.58% |
| 2022 | $0.15 B | -48.06% |
| 2021 | $0.30 B | 499.98% |
| 2020 | $50.81 M | 268.57% |
| 2019 | $13.78 M | -70.72% |
| 2018 | $47.09 M | -20.67% |
| 2017 | $59.36 M | 37.39% |
| 2016 | $43.2 M | -84.99% |
| 2015 | $0.28 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $0.44 B | 120.91% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $6.82 B | 3,304.10% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $1.37 B | 584.02% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.74 M | -98.63% | 🇺🇸 USA |